Fewer Bleeding Events Seen With Abelacimab Than Rivaroxaban in A-Fib
THURSDAY, Jan. 23, 2025 (HealthDay News) -- Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events than rivaroxaban in patients with atrial fibrillation at moderate-to-high risk for stroke, according...